Related Experiment Video
Updated: Aug 9, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Clinical spectrum of symptomatic external iliac fibromuscular dysplasia
L Sauer1, L M Reilly, J Goldstone
1Division of Vascular Surgery, University of California, San Francisco 94143.
Abstract:
External iliac fibromuscular dysplasia is a rare and usually asymptomatic disorder. We report eight symptomatic patients seen over a 15-year period and review pathophysiologic mechanisms accounting for the three following distinct lower extremity ischemic sequelae: (1) Emboli--episodic focal digital ischemia (blue toe) was seen in three patients. Resection and primary anastomosis of focal iliac ulcerative fibromuscular dysplasia (one patient) or resection and replacement (two patients) removed the embolic source and relieved the symptoms. (2) Chronic ischemia--gradual onset of full leg claudication in four patients was treated by operative graduated intraluminal dilation in three patients and prosthetic bypass in one. Arteriography subsequently showed a remodeled lumen in the three patients who underwent dilation. (3) Dissection--acute onset leg ischemia resulted from presumed dissection of the external iliac segment. After 4 months of conservative management of antiplatelet agents and exercise, symptoms resolved completely, and arteriogram showed spontaneous restoration of a normal lumen in the dissected segment. The clinical presentation of fibromuscular dysplasia may mimic other arterial processes such as atherosclerosis. Diagnosis is made only by arteriography with specific magnification views of the external iliac arteries and careful surveillance of the renal arteries. Appropriate treatment should be tailored to the clinical presenting symptom. For microembolic disease, resection and replacement are required. For chronic ischemia, intraluminal dilation is generally sufficient and durable and has proved to be a simpler and acceptable alternative to replacement or bypass. In acute dissection, surgical intervention may be deferred if the limb is viable to allow spontaneous healing and remodeling. Persistent symptoms may be the only indication for intervention in this ischemic manifestation of external iliac fibromuscular dysplasia.
Insights
External iliac fibromuscular dysplasia can cause leg ischemia through emboli, chronic issues, or dissection. Treatment varies from resection and replacement for emboli to dilation for chronic ischemia, with conservative management for dissection.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Radiology
Background:
- External iliac artery fibromuscular dysplasia (FMD) is a rare condition, often asymptomatic.
- This study reviews eight symptomatic cases over 15 years, focusing on lower extremity ischemic sequelae.
Observation:
- Three distinct presentations of lower extremity ischemia were observed: embolic (blue toe), chronic (leg claudication), and dissection.
- Embolic cases involved ulcerative FMD, treated with resection and anastomosis/replacement.
- Chronic ischemia was managed with intraluminal dilation or bypass, while dissection was managed conservatively with spontaneous resolution in one case.
Findings:
- Resection and replacement effectively treated embolic manifestations of external iliac artery FMD.
- Graduated intraluminal dilation provided durable and simpler treatment for chronic leg ischemia compared to bypass.
- Conservative management with antiplatelet agents and exercise allowed spontaneous healing in acute external iliac artery dissection.
Implications:
- Tailoring treatment to the specific ischemic symptom is crucial for managing external iliac artery FMD.
- Arteriography with magnification views is essential for diagnosis, alongside renal artery surveillance.
- Fibromuscular dysplasia can mimic other arterial diseases like atherosclerosis, necessitating careful diagnostic evaluation.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations
Diverticular Disease of the Colon

